Graf Akcie PTCT (PTC Therapeutics Inc). Diskuze k akciím PTCT. Aktuální informace PTCT.

Základní informace o společnosti PTC Therapeutics Inc (Akcie PTCT)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 2.62B
Hodnota podniku (EV) 2.58B
Tržby 471.886M
EBITDA -288.40
Zisk -391.06
Růst v tržbách Q/Q 55.07 %
Růst v tržbách Y/Y 51.55 %
P/E (Cena vůči ziskům) N/A
Forward P/E N/A
EV/Sales 5.47
EV/EBITDA N/A
EV/EBIT N/A
PEG 0.92
Price/Sales 5.55
P/FCF N/A
Price/Book 5.44
Účetní hodnota na akcii 7.00
Hotovost na akcii 16.04
FCF vůči ceně -7.34 %
Počet zaměstnanců 963
Tržba na zaměstnance 490.017k
Profit margin -115.07 %
Operating margin -70.49 %
Gross margin 95.03 %
EBIT margin -56.82 %
EBITDA margin -61.12 %
EPS - Zisk na akcii N/A
EPS - Kvartální růst -39.57 %
EPS - Očekávaný růst příští rok 38.83 %
Return on assets -18.27 %
Return on equity -105.54 %
ROIC -18.09 %
ROCE -15.17 %
Dluhy/Equity 3.58
Čistý dluh/EBITDA 7.88
Current ratio 3.66
Quick Ratio 3.61
Volatilita 3.93
Beta 0.75
RSI 46.85
Cílová cena analytiků 62
Známka akcie (dle analytiků) 2.08
Insider ownership N/A %
Institutional ownership N/A %
Počet akcií 70.605M
Procento shortovaných akcií 9.52 %
Short ratio 9.76 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2013
Země United States

Finanční výsledky akcie PTCT

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$380.766$306.98$264.734$194.392$82.705$36.766
Cost Of Goods Sold$18.942$12.135$12.67$4.577--
Gross Profit$361.824$294.845$252.064$189.815$82.705$36.766
Research And Development Expenses$477.643$257.452$171.984$117.456$117.633$121.816
SG&A Expenses$245.164$202.541$153.548$121.271$97.13$82.08
Other Operating Income Or Expenses$-33.893$-48.36$-19.34---
Operating Expenses$812.534$548.138$380.419$258.684$214.763$203.896
Operating Income$-431.768$-241.158$-115.685$-64.292$-132.058$-167.13
Total Non-Operating Income/Expense$28.836$1.232$-12.425$-13.373$-9.483$-2.832
Pre-Tax Income$-402.932$-239.926$-128.11$-77.665$-141.541$-169.962
Income Taxes$35.228$11.65$-0.029$1.335$0.569$0.485
Income After Taxes$-438.16$-251.576$-128.081$-79$-142.11$-170.447
Other Income------
Income From Continuous Operations$-438.16$-251.576$-128.081$-79$-142.11$-170.447
Income From Discontinued Operations------
Net Income$-438.16$-251.576$-128.081$-79$-142.11$-170.447
EBITDA$-345.467$-210.206$-89.507$-45.642$-126.581$-161.667
EBIT$-431.768$-241.158$-115.685$-64.292$-132.058$-167.13
Basic Shares Outstanding665947393434
Shares Outstanding665947393434
Basic EPS$-6.64$-4.27$-2.75$-2.02$-4.17$-5.07
EPS - Earnings Per Share$-6.64$-4.27$-2.75$-2.02$-4.17$-5.07
# 2020 2019 2018 2017 2016 2015
Current Ratio4.44143.30411.92363.03565.26537.8427
Long-term Debt / Capital0.67280.33090.28720.4810.45090.289
Debt/Equity Ratio2.10220.52810.43630.92670.82130.4064
Gross Margin95.025396.04795.214197.6455100100
Operating Margin-113.3946-78.5582-43.6986-33.0734-159.6735-454.5776
EBIT Margin-113.3946-78.5582-43.6986-33.0734-159.6735-454.5776
EBITDA Margin-90.7295-68.4755-33.8102-23.4794-153.0512-439.7188
Pre-Tax Profit Margin-105.8214-78.1569-48.392-39.9528-171.1396-462.2804
Net Profit Margin-115.0733-81.9519-48.381-40.6395-171.8276-463.5995
Asset Turnover0.17240.18910.23650.49630.30710.1007
Inventory Turnover Ratio1.01310.62920.78610.4256--
Receiveable Turnover5.4455.52743.89854.81243.31763.314
Days Sales In Receivables67.033566.034893.626375.8458110.0186110.1374
ROE - Return On Equity-90.9079-42.3294-36.5187-50.4996-118.8379-75.4187
Return On Tangible Equity138.7957126.731529.6042-336.973-118.838-75.4187
ROA - Return On Assets-19.8417-15.4932-11.4438-20.1709-52.7613-46.6619
ROI - Return On Investment-29.7477-28.3246-26.0288-26.2103-65.2482-53.6252
Book Value Per Share6.91339.59596.93053.75943.49986.6634
Operating Cash Flow Per Share-1.2635-1.0822-0.33672.78530.6555-1.8831
Free Cash Flow Per Share-1.3001-1.1636-0.40982.75820.6843-1.8163